🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT07601256
Starting soon Not applicable

Inhalational Versus Intravenous Anesthesia on Postoperative Lung Injury in Septic Patients Undergoing Surgery

NCT07601256 · tracked via the Priya Life Science China tracker
Sponsor
Sixth Affiliated Hospital, Sun Yat-sen University
Phase
Not applicable
Started
2026-08-15
Last updated
2026-05-22

Condition(s) studied

SepsisLung Injury

Investigational drug(s) / intervention(s)

Inhalation Anesthesiaintravenous anesthesia

Inhalation Anesthesia: The inhalation group will be maintained with inhaled sevoflurane and a continuous intravenous infusion of remifentanil.

intravenous anesthesia: The intravenous group will be maintained with continuous intravenous infusions of both ciprofol and remifentanil.

Study summary

This randomized controlled trial will compare the effects of intraoperative inhalational anesthesia versus intravenous anesthesia on postoperative lung injury in septic patients undergoing surgery. The primary goal is to determine if the choice of anesthetic technique influences the incidence or severity of this complication. Participants will be randomly assigned to one of the two anesthetic regimens during surgery. They will receive daily in-hospital assessments for lung injury and other outcomes and will be followed for clinical outcomes until 90 days after the procedure.

Eligibility

Sex
ALL
Min age
18 Years
Max age
Healthy volunteers
No
Inclusion Criteria: 1. Age ≥ 18 years. 2. Diagnosis of sepsis according to Sepsis-3.0 (highly suspected or confirmed infection with acute increase in SOFA score ≥ 2). 3. Scheduled to undergo surgery under general aaesthesia for source control or sepsis-related operative management. Exclusion Criteria: 1. Already intubated prior to entering the operating room. 2. Chronic home ventilator dependence (e.g., severe chronic obstructive pulmonary disease) before surgery. 3. Personal or family history of malignant hyperthermia. 4. Known allergy to ciprofol or sevoflurane. 5. Known allergy to egg or soy products. 6. Any contraindication to the planned anaesthetic agents. 7. Pregnant women.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
The Sixth Affiliated Hospital of Sun Yat-sen University Guangzhou Guangdong

More Sixth Affiliated Hospital, Sun Yat-sen University trials in China

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07601256 on ClinicalTrials.gov ↗ ← All trials in China